Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOakley Regulatory News (OCI)

Share Price Information for Oakley (OCI)

Share Price is delayed by 15 minutes
Get Live Data
506.00    -6.00 (-1.17%)
Bid:
506.00
Ask:
510.00
Spread: 4.00 (0.791%)
Market Cap: £835.99m
OCI Live PriceLast checked at - London Stock Exchange

Intraday Oakley Share Chart

Director Dealing

31 Jul 2023 12:14

RNS Number : 7456H
Oakley Capital Investments Limited
31 July 2023
Β 

31 July 2023

Β 

Oakley Capital Investments Limited

Β 

Director Dealing

Β 

Oakley Capital Investments Limited1 (the "Company"), was notified today of the following transactions by a Director of the Company:

Fiona Beck, a Director of the Company, has purchased 10,000 Ordinary Shares in the Company ("Ordinary Shares") at an aggregate price of 448 pence per share. As a result, Ms Beck is now interested in 50,000 Ordinary Shares of the Company, representing 0.03% of the issued share capital.

Β 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities/person closely associated

Β 

a)

Name

Β 

Fiona Beck

2

Reason for the notification

Β 

a)

Position/status

Β 

Director

b)

Initial notification/ Amendment

Β 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Name

Β 

Oakley Capital Investments Limited

b)

LEI

Β 

213800KW6MZUK12CQ815

Β 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary Shares of 1p each

Β 

Β 

Β 

Β 

Β 

BMG670131058

b)

Nature of the transaction

Β 

Acquisition

c)

Price(s) and volume(s)

Β 

Β 

Price(s)

Volume(s)

446p

Β 

449p

2,000

Β 

8,000

d)

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

Β 

Β 

Β 

10,000

Β 

Β 

448p

e)

Date of the transaction

Β 

28 July 2023

f)

Place of the transaction

Β 

London Stock Exchange, Specialist Fund Segment

Β 

Β 

- ends -

Β 

For further information please contact:

Β 

Oakley Capital Limited

+44 20 7766 6900

Steven Tredget

Β 

Greenbrook Communications Limited

+44 20 7952 2000

Rob White / Michael Russell

Β 

Liberum Capital Limited (Financial Adviser & Broker)

+44 20 3100 2000

Chris Clarke / Darren Vickers / Owen Matthews

Β 

Notes:

LEI Number: 213800KW6MZUK12CQ815

1Β About Oakley Capital Investments Limited ("OCI")

OCI is aΒ Specialist Fund Segment ("SFS")Β traded investment vehicle that aims to provide shareholders with consistent long-term capital growth in excess of the FTSE All-Share Index by providing liquid access to private equity returns through investment in the Oakley Funds2.

A video introduction to OCI is available atΒ https://oakleycapitalinvestments.com/videos/

The contents of the OCI website are not incorporated into, and do not form part of, this announcement.

Oakley Capital, the Investment Adviser

Founded in 2002, Oakley Capital Limited has demonstrated the repeated ability to source attractive growth assets at attractive prices. To do this it relies on its sector and regional expertise, its ability to tackle transaction complexity and its deal generating entrepreneur network.

The Oakley Funds

Oakley Capital Private Equity L.P. and its successor funds, Oakley Capital Private Equity II, Oakley Capital Private Equity III, Oakley Capital IV, Oakley Capital V and Oakley Capital Origin Fund and are unlisted lower-mid to mid-market private equity funds that aim to provide investors with significant long-term capital appreciation. The investment strategy of the Funds is to focus on buy-out opportunities in industries with the potential for growth, consolidation and performance improvement. The Oakley family of funds also includes Oakley PROfounders Fund III and Oakley Touring Venture Fund, which are venture capital funds focused on investments in entrepreneur-led, disruptive, technology led companies.

For more information on the Oakley Fund strategies in which OCI invests, please click here.

Important information

Specialist Fund Segment securities are not admitted to the Official List of the Financial Conduct Authority. Therefore, the Company has not been required to satisfy the eligibility criteria for admission to listing on the Official List and is not required to comply with the Financial Conduct Authority's Listing Rules.

The Specialist Fund Segment is intended for institutional, professional, professionally advised and knowledgeable investors who understand, or who have been advised of, the potential risk from investing in companies admitted to the Specialist Fund Segment.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHFFLFXXDLFBBX
Date   Source Headline
18th Mar 20207:00 amRNSShare Buy-Back
17th Mar 20204:42 pmRNSSecond Price Monitoring Extn
17th Mar 20204:38 pmRNSPrice Monitoring Extension
12th Mar 20207:33 amRNSResults analysis from Kepler Trust Intelligence
12th Mar 20207:00 amRNSFinal Annual Results 2019
4th Mar 20207:00 amRNSAcquisition of Globe-Trotter
24th Feb 20207:00 amRNSOakley agrees sale of atHome
30th Jan 20207:00 amRNSDirector Dealing
29th Jan 20207:00 amRNSTrading update for the year ended 31 December 2019
24th Dec 20199:00 amRNSUpdate on Rastreator and Acierto
23rd Dec 20193:06 pmRNSHolding(s) in Company
20th Dec 20194:52 pmRNSDirector/PDMR Shareholding
20th Dec 20193:42 pmRNSTransaction in Own Shares
20th Dec 20192:27 pmRNSShare Buy-Back
16th Dec 20197:00 amRNSAppointment of Non-Executive Director
12th Dec 20197:00 amRNSOakley agrees sale of WebPros to CVC
3rd Dec 20197:00 amRNSHolding(s) in Company
15th Nov 20197:00 amRNSDirector Dealing
15th Nov 20197:00 amRNSDirector Dealing
14th Nov 20193:45 pmRNSTransaction in Own Shares
14th Nov 20197:00 amRNSShare Buy-back
18th Oct 20194:58 pmRNSHolding(s) in Company
13th Sep 20197:00 amRNSDirector/PDMR Shareholding
11th Sep 20197:00 amRNSResults for the six months ended 30 June 19
29th Aug 20197:00 amRNSInvestment in leading design company Alessi
23rd Aug 20198:00 amRNSAdmission to the Specialist Fund Segment
23rd Aug 20197:00 amRNSResult of Annual General Meeting
20th Aug 20195:30 pmRNSOakley Capital Investments
15th Aug 20197:00 amRNSAcquisition of Seven Miles
26th Jul 20197:00 amRNSNotice of AGM
24th Jul 20197:00 amRNSTrading update for the six months ended 30 June 19
18th Jul 20196:11 pmRNSPublication of Prospectus
18th Jul 20197:01 amRNSProposed move to SFS & AIM cancellation
18th Jul 20197:00 amRNSDirectorate Change
20th Jun 201912:50 pmRNSAnnual Report and Accounts and Shares in Issue
20th Jun 20197:00 amRNSHolding(s) in Company
20th Jun 20197:00 amRNSHolding(s) in Company
20th Jun 20197:00 amRNSHolding(s) in Company
18th Jun 20197:00 amRNSDirector/PDMR Shareholding
18th Jun 20197:00 amRNSHolding(s) in Company
18th Jun 20197:00 amRNSHolding(s) in Company
18th Jun 20197:00 amRNSDirector/PDMR Shareholding
30th May 20197:00 amRNSInspired welcomes Warburg Pincus as an Investor
13th May 201911:52 amRNSAcquisition of Videotel and Seagull
1st May 20197:00 amRNSAcquisition of stake in Rastreator and Acierto
5th Apr 20192:45 pmRNSHolding(s) in Company
2nd Apr 20192:00 pmRNSKepler Trust Intelligence: New Research
25th Mar 20197:00 amRNSAcquisition of Ekon
15th Mar 20197:00 amRNSTransaction in Own Shares
14th Mar 20197:00 amRNSShare buy-back

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.